Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00682994 · ClinicalTrials.gov registry record · NA

Patient and Family Decision Making in the Palliative Care Setting

A NA study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
780
Enrollment target

NCT00682994: Completed NA study, sponsored by M.D. Anderson Cancer Center.

NCT00682994 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 780 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00682994, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
780 participants
Enrollment target

Study Summary

The goal of this research study is to learn about any differences in certain health-related preferences between patients with cancer and their families. The main preferences being studied are how decisions are made about healthcare, as well as how much information people want to know about cancer. Specifically, researchers will compare questionnaire and interview data from Hispanic-Americans living in the United States (the M. D. Anderson part of this multicenter study) with Hispanics living in Latin America (in particular, Argentina, Chile, and Guatemala).

Interventions

  • BEHAVIORAL Questionnaire
  • BEHAVIORAL Interview

Trial Details

FieldValue
Enrollment Target 780 participants
Start Date 2008-03
Est. Completion 2012-08
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT00682994 record still lists

NCT00682994 is an interventional study that assigns participants to a tested intervention. The registered 780 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower).

The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.

NCT00682994 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00682994 about?

NCT00682994 is a clinical study titled "Patient and Family Decision Making in the Palliative Care Setting". The goal of this research study is to learn about any differences in certain health-related preferences between patients with cancer and their families. The main preferences being studied are how decisions are made about healthcare, as well as how much information people want to know about cancer. ...

What is the current status of trial NCT00682994?

This trial is currently completed. It is a NA study. The enrollment target is 780 participants. The study started on 2008-03. Estimated completion is 2012-08.

What interventions are being tested in trial NCT00682994?

The interventions under investigation include: Questionnaire (BEHAVIORAL), Interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT00682994?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00682994's enrollment target sits among peer trials

780 141st of 2000 higher than 1,859 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05046613 · 780 participants

    Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

  • NCT05100862 · 780 participants · Phase 3

    A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  • NCT05513872 · 780 participants · Phase 1

    Overcoming Nicotine Dependence to Enable Quitting

  • NCT06310031 · 780 participants · NA

    Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00682994, the US trial registry maintained by the National Library of Medicine. NCT00682994 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.